The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

Biocon launches Liraglutide injection (Diavorin & Vobexoryn) for diabetes and weight management in the Netherlands with ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, ...

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

Biocon announced the launch of its GLP-1 peptide, Liraglutide, for diabetes (gVictoza) and obesity (gSaxenda), in the Netherlands through its distribution partner Pharmamedic B.V. The drug-device ...

Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for ...

The European Medicines Agency's committee on Friday recommended extending ‍the use of Eli Lilly's blockbuster drug Mounjaro ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

Novo Nordisk has launched its diabetes medication Ozempic in India, a significant move amid increasing demand for diabetes ...